Hongliang Xue

机构：First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University · ORCID：0000-0002-9437-6396

发表论文 32 篇 · 总被引 1115 次 · h-index 13

代表论文

• Gut Microbially Produced Indole-3-Propionic Acid Inhibits Atherosclerosis by Promoting Reverse Cholesterol Transport and Its Deficiency Is Causally Related to Atherosclerotic Cardiovascular Disease (2022 · Circulation Research · 被引 271)
• Epigenetic modulation of Drp1-mediated mitochondrial fission by inhibition of S-adenosylhomocysteine hydrolase promotes vascular senescence and atherosclerosis (2023 · Redox Biology · 被引 86)
• Hepatic steatosis aggravates atherosclerosis via small extracellular vesicle-mediated inhibition of cellular cholesterol efflux (2023 · Journal of Hepatology · 被引 85)
• Association of MAFLD with end-stage kidney disease: a prospective study of 337,783 UK Biobank participants (2023 · Hepatology International · 被引 43)
• Associations of MAFLD and MAFLD subtypes with the risk of the incident myocardial infarction and stroke (2023 · Diabetes & Metabolism · 被引 32)
• iMeta Conference 2024: Building an innovative scientific research ecosystem for microbiome and One Health (2024 · iMeta · 被引 18)